OTLK Stock Analysis: Buy, Sell, or Hold?
OTLK - Outlook Therapeutics, Inc. Common Stock
$0.44
-0.02 (-4.39%)
▼
WAIT
LOW Confidence
Last Updated: January 30, 2026
Earnings: Feb 13, 2026
12d
Smart Money Accumulation
OTLK is down 12.6% this week, but smart money is accumulating calls. Top strike: $0.5 2026-03-20 with 2 OI. Call ratio: 100% View Scanner →
Strength: 10.0/10
Get Alerted When OTLK Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
9 traders called OTLK this week
83% bullish • 2 bearish
83% bullish • 2 bearish
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR STABILIZATION: OTLK is down 12.6% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
⏸️ WAIT FOR STABILIZATION: OTLK is down 12.6% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
In-depth Analysis How we analyze
Valuation Analysis: OTLK is currently trading at $0.44, which is considered slightly low relative to its 30-day fair value range of $0.30 to $1.44.
Technical Outlook: Technically, OTLK is in a uptrend. Immediate support is located at $0.42, while resistance sits at $0.56. Short-term momentum is weak, with the stock down 4.4% recently.
Market Sentiment: OTLK has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $5.38 (+1068.7%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, OTLK is in a uptrend. Immediate support is located at $0.42, while resistance sits at $0.56. Short-term momentum is weak, with the stock down 4.4% recently.
Market Sentiment: OTLK has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $5.38 (+1068.7%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Fair Price Range
$0.30 -
$1.44
Company Quality Score
50/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
89.5%
Protect Your Profits
Holding OTLK? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BULLISH: Price oversold vs 30-day range
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-4.4%)
- BULLISH: Trading 1068.7% below Wall St target ($5.38)
- WARNING: Recommendation downgraded due to -12.6% 5-day decline - wait for stabilization
Fair Price Analysis
30-Day Fair Range
$0.30 -
$1.44
Current vs Fair Value
SLIGHTLY LOW
Support & Resistance Levels
Support Level
$0.42
Resistance Level
$0.56
Current Trend
Uptrend
Fundamental Context
Forward P/E (Next Year Est.)
-1.13
Wall Street Target
$5.38
(+1068.7%)
Revenue Growth (YoY)
658.3%
Last updated: January 31, 2026 5:57 AM ET
Data refreshes hourly during market hours. Next update: 6:57 AM
Data refreshes hourly during market hours. Next update: 6:57 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is OTLK showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
SRPT
Sarepta Therapeutics Inc |
STRONG BUY
26 analysts |
$21 | 54 HOLD |
|
INSM
Insmed Inc |
STRONG BUY
19 analysts |
$214 | 60 BUY |
|
RCKT
Rocket Pharmaceuticals I… |
STRONG BUY
18 analysts |
$8 | 53 HOLD |
|
ACAD
ACADIA Pharmaceuticals I… |
BUY
20 analysts |
$31 | 55 HOLD |
|
ORIC
Oric Pharmaceuticals Inc |
STRONG BUY
12 analysts |
$21 | 58 HOLD |
Advanced OTLK Option Strategies
Professional options setups generated by AI based on today's OTLK price and gamma walls.
